期刊文献+

哺乳动物雷帕霉素靶蛋白小分子干扰RNA对食管鳞癌细胞中mTOR-p70S6K信号通路及裸鼠移植瘤生长的影响 被引量:2

Effects of roTOR siRNA on mTOR/p70S6K signaling pathway in esophageal squamous cell carcinoma cells and the growth of transplanted tumor in nude mice
原文传递
导出
摘要 目的 检测哺乳动物雷帕霉素靶蛋白(mTOR)小分子干扰RNA(siRNA)对食管鳞癌中mTOR-p70S6K信号通路的阻断作用以及对裸鼠移植瘤生长的影响.方法 以食管鳞癌细胞株EC9706为研究对象,采用siRNA干扰、逆转录聚合酶链反应(RT-PCR)、Western blot、流式细胞术及CCK-8等方法,观察mTOR-p70S6K信号通路被阻断后,通路中各因子蛋白及mRNA表达的变化,及其对细胞增殖和凋亡的影响.进行裸鼠成瘤实验,观察mTOR siRNA对肿瘤生长的影响.结果 与未转染细胞相比,转染mTOR siRNA的细胞中mTOR和磷酸化p70S6K的表达水平降低(P〈0.05),而pTOS6K的表达水平升高(P〈0.05).转染mTOR siRNA后,细胞凋亡增加,细胞增殖能力降低,且对顺铂的敏感性增高,细胞被阻滞在G,期(P〈0.05).mTOR siRNA能明显抑制裸鼠移植瘤的生长,siRNA组和siRNA+顺铂组的肿瘤抑制率分别为50.9%和62.3%.结论 mTOR siRNA能有效抑制mTOR-pTOS6K信号通路,抑制细胞增殖,促进细胞凋亡,在裸鼠体内能显著抑制肿瘤的生长.mTOR-pVOSSK信号通路在食管鳞癌发生发展中起重要作用. Objective To investigate the effects of mTOR siRNA on mTOR-p70S6K signaling pathway in esophageal squamous cell carcinoma ( ESCC) cells in vitro, and growth and apoptosis in transplanted tumor in nude mice. Methods mTOR siRNA was transfected into ESCC cell line EC9706 cells. The expressions of factors of the mTOR/p70S6K signaling pathway were detected by RT-PCR and Western blot. DNA contents and cell apoptosis were determined by flow cytometry, and cell proliferation was measured by CCK-8 assay. The effects of mTOR siRNA on the transplanted tumor growth were assessed in nude mice. Results The levels of mTOR and p-p70S6K were significantly decreased ( P 〈 0.05 ) while the level of p70S6K was increased (P〈0.05) in the cells transfected with mTOR siRNA, compared with that in untransfected cells and cells transfected with control siRNA. After being interfered by mTOR siRNA, the number of apoptotic cells was increased, cell proliferation became slower and cell cycle was arrested in G, phase compared with that in control cells. Also, mTOR siRNA inhibited the growth of transplanted tumor in vivo. Conclusions mTOR siRNA can effectively interfere in mTOR-p70S6K signaling pathway, induce cell apoptosis and inhibit cell proliferation and tumor growth, suggesting that mTOR-p70S6K signaling pathway plays an important role in the carcinogenesis and development of esophageal squamous cell carcinoma.
出处 《中华肿瘤杂志》 CAS CSCD 北大核心 2011年第5期334-339,共6页 Chinese Journal of Oncology
基金 国家自然科学基金(30901778)
关键词 食管肿瘤 RNA干扰 流式细胞术 mTOR-p70S6K信号通路 裸鼠 Esophageal neoplasms RNA interference Flow cytometry mTOR-p70S6Kpathway Nude mice
  • 相关文献

参考文献13

  • 1Hay N,Sonenberg N.Upstream and downstream of mTOR.Goies Dot,200*,18:1926-1945.
  • 2Jefferies HB,Fumagalli S,Dennis FB,et al.Rapamycin suppresses 5' TOP mRNA translation through inhibition of p70s6k.EMBO J,1997,16:3693-3704.
  • 3Camevalli LS,Masuda K,Frigerio F,et al.S6K1 plays a critical role in early adipocyte differentiation.Dev Cell,2010,18:763-774.
  • 4Smolewslri P.Recent developments in targeting the mammalian target of rapamycin (mTOR) kinase pathway.Anticancer Drugs,2006,17:487-494.
  • 5Easier CA 4th,Ben-Yehudah A,Redmger CJ,et al.mTOR-mediated activation of p70 S6K induces differentiation of pluripotent human embryonic stem cells.Cell Reprogram,2010,12:263-273.
  • 6Pal SK,Figlin RA,Reckamp KL The role of targeting mammalian target of rapamycin in lung cancer.Clin Lung Cancer,2008,9; 340-345.
  • 7GeorgakisGV,Younes A.From Rapa Nui to rapamycin:targeting P13K/Akt/mTOR for cancer therapy,Expert Rev Anticancer Ther,2006,6:131-140.
  • 8Faried LS,Faried A,KanumaT,et al.Expression of an activated mammalian target of rapamycin in adenocarcinoma of the cervix:a potential biomarker and molecular target therapy.Mol Carcinog,2008,47:446457.
  • 9Zhang YJ,Dai Q,Sun DF,et al.mTOR signaling pathway is a target for the treatment of colorectal cancer,Ann Surg Oncol,2009,6:2617-2628.
  • 10Albert JM,Kim KW,CaoC,et al.Targeting the Akt/mammalian target of rapamycin pathway for radiosensitization of breast cancer.Mol Cancer Ther,2006,5:1183-1189.

二级参考文献12

  • 1Pene F,Claessene YE,Muller O,et al.Role of the phosphatidylinositol 3-kinase/Akt and mTOR/p70S6-kinase pathways in the proliferation and apoptosis in multiple myeloma[J].Oncogene,2002,21(43):6 587
  • 2Panwalker A,Verstovsek S,Giles FJ.Mammalian target of rapamycin inhibition as therapy for hematologic malignancies[J].Cancer,2004,100(4):657
  • 3Bjornsti MA,Houghton PJ.The TOR pathway:a target for cancer therapy[J].Nat Rev Cancer,2004,4(5):335
  • 4Albert JM,Kim KW,Cao C,et al.Targeting the Akt/mammalian target of rapamycin pathway for radiosensitization of breast cancer[J].Mol Cancer Ther,2006,5(5):1 183
  • 5Pisani P,Parkin DM,Bray F,et al.Estimates of the worldwide mortality from 25 cancers in 1990[J].Int J Cancer,1999,83(1):18
  • 6Montesano R,Hollstein M,Hainant P.Genetic alterations in esophageal cancer and their relevance to etiology and pathogenesis:a review[J].Int J Cancer,1996,69(3):225
  • 7Fingar DC,Richardson CJ,Tee AR,et al.mTOR controls cell cycle progression through its cell growth effector S6K1 and 4EBP1/eukaryotic translation initiation factor 4E[J].Mol Cell Biol,2004,24(1):200
  • 8Morgensztern D,McLeod HL.PI3K/Akt/mTOR pathway as a target for cancer therapy[J].Anticancer Drugs,2005,16(8):797
  • 9Tolcher AW.Novel therapeutic molecular targets for prostate cancer:the mTOR signaling pathway and epidermal growth factor receptor[J].J Urol,2004,171(2 Pt 2):S41
  • 10Altomare DA,You H,Xiao GH,et al.Human and mouse mesotheliomas exhibit elevated AKT/PKB activity,which can be targeted pharmacologically to inhibit tumor cell growth[J].Oncogene,2005,24(40):6 080

共引文献10

同被引文献28

  • 1崔仑标,戴贵东,王心如.细胞周期素与膀胱癌关系的研究进展[J].中国肿瘤,2005,14(2):111-114. 被引量:3
  • 2Guba M,B reitenbuch PV,Steinbauer M,et al.Rapamycin in-hibits primary and metastasis tumor growth by antiangi ogenesis in-volvement of vascular endothelial growth factor[J].Nat Med,2002,8(4):128.
  • 3Raught B,Gingras AC,Sonenberg N.The target of rapamycin(TOR)proteins[J].RNAS,2001,98(7):7037.
  • 4Sherri CJ,Roberts JM.CDK inhibitors:Positive and negative reg-ulators of G 1-phase progression[J].Genes Dev,1999,13:1501-1512.
  • 5Abraham RT,Wiederrecht GJ.Rapamycin has a deleterious effect[J].Ann Rev Inmmunol,1996,14(3):483.
  • 6Hudson CC,Liu M,Chiang GG,et al.Regulation of hypoxia-inducible factor Ialpha expression and function by the mammalian target of rapamycin[J].Mol Cell Biol,2002,22(20):7004-7014.
  • 7Miriuka SG,Rao V,Peterson M,et al.mTOR inhibition induces endothelial progenitor cell death[J].Am J Transplant,2006,6(11):2069-2079.
  • 8Butzal M,Loges S,Schweizer M,et al.Rapamycin inhibits pro-liferation and differentiation of human endothelial progenitor cells in vitro[J].Exp Cell Res,2004,300(1):65-71.
  • 9吴阶平.吴阶平泌尿外科学[M].济南:山东科学技术出版社,2004.589-591.
  • 10Pfannschmidt J, Muley T, Biilzebruck H, et al. Prognostic assessment after surgical resection for non-small cell lung cancer: experiences in 2083 patients[ J]. Lung Cancer, 2007, 55 (3) :371-377.

引证文献2

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部